These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27980399)

  • 21. Power Outage: An Ignored Risk Factor for COPD Exacerbations.
    Zhang W; Sheridan SC; Birkhead GS; Croft DP; Brotzge JA; Justino JG; Stuart NA; Du Z; Romeiko XX; Ye B; Dong G; Hao Y; Lin S
    Chest; 2020 Dec; 158(6):2346-2357. PubMed ID: 32502591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of medical expenditure with nebulized budesonide versus systemic corticosteroids in hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease in China.
    Zhang J; Yao W; You X; Liu T; Liu Y
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1195-1207. PubMed ID: 31213797
    [No Abstract]   [Full Text] [Related]  

  • 23. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
    Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
    J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How do COPD comorbidities affect ICU outcomes?
    Ongel EA; Karakurt Z; Salturk C; Takir HB; Burunsuzoglu B; Kargin F; Ekinci GH; Mocin O; Gungor G; Adiguzel N; Yilmaz A
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1187-96. PubMed ID: 25378919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient Outcome after Chronic Obstructive Pulmonary Disease Exacerbations Requiring Non-invasive Ventilation during Hospitalization.
    Tokgoz Akyil F; Gunen H; Agca M; Gungor S; Yalcinsoy M; Sucu P; Akyil M; Sevim T
    Arch Bronconeumol; 2016 Sep; 52(9):470-6. PubMed ID: 27156204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rising total costs and mortality rates associated with admissions due to COPD exacerbations.
    Molinari N; Chanez P; Roche N; Ahmed E; Vachier I; Bourdin A
    Respir Res; 2016 Nov; 17(1):149. PubMed ID: 27842545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.
    Ke X; Marvel J; Yu TC; Wertz D; Geremakis C; Wang L; Stephenson JJ; Mannino DM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1689-703. PubMed ID: 27555759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COPD exacerbation frequency and its association with health care resource utilization and costs.
    Dhamane AD; Moretz C; Zhou Y; Burslem K; Saverno K; Jain G; Renda A; Kaila S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2609-18. PubMed ID: 26664109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
    Chiang CH
    Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease.
    Dalal AA; Roberts MH; Petersen HV; Blanchette CM; Mapel DW
    Int J Chron Obstruct Pulmon Dis; 2010 Dec; 6():13-22. PubMed ID: 21311689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prompt initiation of maintenance treatment following a COPD exacerbation: outcomes in a large insured population.
    Coutinho AD; Lokhandwala T; Boggs RL; Dalal AA; Landsman-Blumberg PB; Priest J; Stempel DA
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1223-31. PubMed ID: 27354781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.
    Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health-care utilization and expenditures among patients with comorbid bronchiectasis and chronic obstructive pulmonary disease in US clinical practice.
    Seifer FD; Hansen G; Weycker D
    Chron Respir Dis; 2019; 16():1479973119839961. PubMed ID: 30961354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost of Severe Chronic Obstructive Pulmonary Disease Exacerbations in a High Burden Region in North India.
    Koul PA; Nowshehr AA; Khan UH; Jan RA; Shah SU
    Ann Glob Health; 2019 Jan; 85(1):. PubMed ID: 30741514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Retrospective analysis of direct costs of hospital treatment of chronic obstructive pulmonary disease exacerbations].
    Jahnz-Rózyk K; Targowski T; From S; Płusa T
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():91-4. PubMed ID: 15524028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Costs of chronic obstructive pulmonary disease in patients treated in ambulatory care in Poland].
    Jahnz-Różyk K; Targowski T; From S; Faluta T; Borowiec L
    Pneumonol Alergol Pol; 2011; 79(5):337-42. PubMed ID: 21861257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of outpatient and inpatient costs of moderate and severe exacerbations of chronic obstructive pulmonary disease in Poland].
    Jahnz-Rózyk K; Targowski T; From S
    Pneumonol Alergol Pol; 2008; 76(6):426-31. PubMed ID: 19173191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity and Severity of Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Goto T; Hirayama A; Faridi MK; Camargo CA; Hasegawa K
    Ann Am Thorac Soc; 2018 Feb; 15(2):184-191. PubMed ID: 29053337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of the Aerobika* oscillating positive expiratory pressure device in the management of COPD exacerbations.
    Khoudigian-Sinani S; Kowal S; Suggett JA; Coppolo DP
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3065-3073. PubMed ID: 29089755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics, treatment patterns, and socio-economic burden of COPD in Bulgaria.
    Kamusheva M; Dimitrova M; van Boven JF; Postma MJ; van der Molen T; Kocks JW; Mitov K; Doneva M; Petrova D; Georgiev O; Petkova V; Petrova G
    J Med Econ; 2017 May; 20(5):503-509. PubMed ID: 28058859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.